Diabetic retinopathy: management update

Area of Science:

• Ophthalmology
• Endocrinology
• Public Health

Background:

• Diabetic retinopathy is a major cause of blindness worldwide, affecting individuals with both type 1 and type 2 diabetes.
• Its incidence and severity are linked to diabetes duration, glycemic control, and comorbidities like hypertension and dyslipidemia.
• The condition presents a significant public health challenge, particularly in regions like Nigeria where its prevalence is high.

Purpose of the Study:

• To comprehensively review the current understanding of diabetic retinopathy, encompassing its epidemiology, pathophysiology, classification, clinical presentation, and management strategies.
• To highlight the specific impact and management challenges of diabetic retinopathy in the Nigerian context.

Main Methods:

• A review of current knowledge synthesized from multi-center controlled clinical trials and global epidemiological studies.
• Analysis of data pertaining to the incidence, risk factors, and outcomes of diabetic retinopathy.

Main Results:

• Diabetic retinopathy affects all ocular tissues, with a 33% incidence in Nigerian diabetics, contributing significantly to retinal diseases and blindness.
• Key risk factors include duration of diabetes, poor glycemic control, hypertension, dyslipidemia, and smoking.
• Strict glycemic control and timely surgical interventions (laser, vitrectomy) are crucial for preventing severe vision loss.

Conclusions:

• Optimal management of diabetic retinopathy requires stringent blood sugar control and prompt surgical treatment.
• There is an urgent need for established care guidelines for diabetes and its complications in Nigeria, mirroring those in developed countries.
• Medical therapies for diabetic retinopathy are still under investigation.